Complete MNMD Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
MNMD Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 9 peer companies in Healthcare
P/E Ratio
$-55.66
-815.0%
Peer Median: 62.5x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.6x
P/S Ratio
$0.00
-100.0%
Peer Median: 9.4x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for MNMD's business model and current situation.
Multiple Comparison
| Multiple | MNMD Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -8.7x | 62.5x | 62.5x | -114.0% | Undervalued |
| EV/EBITDA | Infinityx | 45.6x | 45.6x | Infinity% | Overvalued |
| P/S Ratio | Infinityx | 9.4x | 8.1x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.85B | 0.0x | 0.0x | 77.4x | |
| $0.65B | 0.0x | 0.0x | 2.4x | |
| $0.72B | 0.0x | 0.0x | 0.0x | |
| $0.59B | 0.0x | 0.0x | 0.0x | |
| $0.45B | 0.0x | 0.0x | 9.4x | |
| $0.57B | 0.0x | 0.0x | 229.1x | |
| $0.54B | 0.0x | 0.0x | 1.3x | |
| $0.50B | 0.0x | 0.0x | 12.4x | |
| $729.91B | 62.5x | 45.6x | 14.9x |